Keith Michael Gottesdiener Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Keith Michael Gottesdiener is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 8,111 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $154,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Keith Michael Gottesdiener Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$154,109 $19.0 p/Share	8,111 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$469,661 $19.0 p/Share	24,719 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 19.81%	32,830 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 23.84%	24,719 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	7,029 Added 29.27%	16,982 Common Stock

Also insider at

PRME

Prime Medicine, Inc.

Director

KMG